The Herald of Everett, Washington
Customer service  |  Subscribe   |   Log in or sign up   |   Advertising information   |   Contact us
Heraldnet.com

The top local business stories in your email

Contact Us:

Josh O'Connor
Publisher
Phone: 425-339-3007
joconnor@heraldnet.com

Maureen Bozlinski
General Sales Manager
Phone: 425-339-3445
Fax: 425-339-3049
mbozlinksi@heraldnet.com

Jim Davis
Editor
Phone: 425-339-3097
jdavis@heraldnet.com

Site address:
1800 41st Street, S-300,
Everett, WA 98203

Mailing address:
P.O. Box 930
Everett, WA 98206

HBJ RSS feeds

Optimer removes chairman, fires 2 other executives

SHARE: facebook Twitter icon Linkedin icon Google+ icon Email icon |  PRINTER-FRIENDLY  |  COMMENTS
Associated Press
Published:
SAN DIEGO -- Optimer Pharmaceuticals said Monday that its board ousted its chairman and fired its chief financial officer and another executive, because of compliance issues related to the chairman's involvement with one of the company's subsidiaries.
The company's shares fell more than 6 percent in midday trading.
Michael Chang was removed as chairman, while John Prunty, the company's chief financial officer, and Youe-Kong Shue, who served as a vice president, were both fired.
Chang remains a company director, but the board has asked him to resign, Optimer said.
The San Diego-based company's board subsequently named Hank McKinnell, who last month was appointed lead independent director, as its new chairman. The company also said that Kurt Hartman, its general counsel, chief compliance officer and senior vice president, would serve as acting CFO.
The company said that the moves aren't expected to materially affect its revenue or operations. But it also said Monday that it expects to post first-quarter revenue of about $16.5 million, well below average Wall Street predictions of $29.4 million, according to a FactSet poll.
The company said it removed Chang as chairman because of his actions as a member of the board of Taiwan-based Optimer Biotechnology, in which Optimer holds a 43 percent stake, along with his failure to manage compliance and conflict of interest issues after Optimer Biotechnology granted him 1.5 million of its shares.
Optimer said the board fired Prunty and Shue because they failed to follow proper procedures when they found out about the issues related to the shares. The company said the board also plans to remove Chang from Optimer Biotechnology's board and replace him with. McKinnell.
A call to the company seeking comment from the three executives who have been dismissed was not immediately returned.
The company said that it has informed the appropriate federal authorities and is cooperating with them in their reviews.

MORE HBJ HEADLINES

CALENDAR

Share your comments: Log in using your HeraldNet account or your Facebook, Twitter or Disqus profile. Comments that violate the rules are subject to removal. Please see our terms of use. Please note that you must verify your email address for your comments to appear.

You are logged in using your HeraldNet ID. Click here to update your profile. | Log out.

Our new comment system is not supported in IE 7. Please upgrade your browser here.

comments powered by Disqus

Market roundup